Drug panel may review Gennova’s mRNA Omicron booster vaccine
New Delhi: The topic consultants committee (SEC) beneath the drug regulatory authority is prone to assessment India's first mRNA-based Omicron ...
New Delhi: The topic consultants committee (SEC) beneath the drug regulatory authority is prone to assessment India's first mRNA-based Omicron ...
Copyright © 2022 Asia Today.